CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- 4 Shares withheld for taxes EVP and CMO gave up 3,804 shares (to pay taxes)
- 4 Planned sale EVP and Chief Legal Officer sold 988 shares at $499.00 ($493,012)
- 4 Planned sale Director sold 266 shares at $500.00 ($133,000)
- 4 Shares withheld for taxes EVP, Chief Technical Ops. Off. gave up 1,903 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Accounting Officer gave up 1,393 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CO & FO gave up 3,045 shares (to pay taxes)
- 4 Planned sale EVP, Chief Reg. & Quality Off. sold 466 shares at $460.43 ($214,560)
- 4 Shares withheld for taxes EVP Chief Patient & Ext Af Off gave up 2,057 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 1,127 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 8,297 shares (to pay taxes)
- 4 Planned sale EVP, Chief Scientific Officer sold 2,021 shares at $460.43 ($930,529)
- 4 Shares withheld for taxes EVP and CMO gave up 2,145 shares (to pay taxes)
- 4 Planned sale EVP and Chief Legal Officer sold 1,925 shares at $460.43 ($886,328)
- 4 Planned sale EVP, Chief Technical Ops. Off. sold 1,751 shares at $460.43 ($806,213)
- 4 Planned sale SVP & Chief Accounting Officer sold 1,376 shares at $460.43 ($633,552)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, CO & FO acquired 13,600 shares (grant or award)
- 4 Grant or award EVP, Chief Reg. & Quality Off. acquired 11,749 shares (grant or award)
- 4 Grant or award EVP Chief Patient & Ext Af Off acquired 11,749 shares (grant or award)
- 4 Grant or award EVP, Chief Commercial Officer acquired 6,800 shares (grant or award)
Page 5 of 129 · 2,568 filings